The authors demonstrated that the administration of succinate to TNF∆ARE/ + mice (mutants with chronic inflammatory arthritis and IBD) and to anti-CD3E-treated mice (another animal model of intestinal inflammation involving infiltrative disease of the small intestine) reduces intestinal inflammation and modulates the immune response in a tuft cell-dependent manner55. Here, CD3E is linked to inflammatory bowel disease.